Cemiplimab (anti-PD-1)

製品コード：A2022         Batch: A202203

印刷

Cemiplimab (anti-PD-1) is an intravenous human monoclonal antibody directed against programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands 1 (PD-L1) and 2 (PD-L2). Cemiplimab blocks T-cell inactivation and enhances the immune system's anti-tumor response.

製品説明

CAS No. 1801342-60-8
Formulation PBS buffer. Contains no stabilizers or preservatives
Isotype Human IgG4
Source HEK293
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 4.02mg/ml
Endotoxin Level <1 EU/mg

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Variable PD-1 glycosylation modulates the activity of immune checkpoint inhibitors [ Life Sci Alliance, 2024, 7(3)e202302368] PubMed: 38176728

人間や獣医の診断であるか治療的な使用のためにでない。